376 related articles for article (PubMed ID: 18371028)
1. Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats.
Levy JK; Crawford PC; Kusuhara H; Motokawa K; Gemma T; Watanabe R; Arai S; Bienzle D; Hohdatsu T
J Vet Intern Med; 2008; 22(2):330-4. PubMed ID: 18371028
[TBL] [Abstract][Full Text] [Related]
2. Determining the feline immunodeficiency virus (FIV) status of FIV-vaccinated cats using point-of-care antibody kits.
Westman ME; Malik R; Hall E; Sheehy PA; Norris JM
Comp Immunol Microbiol Infect Dis; 2015 Oct; 42():43-52. PubMed ID: 26459979
[TBL] [Abstract][Full Text] [Related]
3. Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats.
Kusuhara H; Hohdatsu T; Seta T; Nemoto K; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
Vet Microbiol; 2007 Mar; 120(3-4):217-25. PubMed ID: 17141431
[TBL] [Abstract][Full Text] [Related]
4. Effect of vaccination against feline immunodeficiency virus on results of serologic testing in cats.
Levy JK; Crawford PC; Slater MR
J Am Vet Med Assoc; 2004 Nov; 225(10):1558-61. PubMed ID: 15568388
[TBL] [Abstract][Full Text] [Related]
5. Diagnosing feline immunodeficiency virus (FIV) infection in FIV-vaccinated and FIV-unvaccinated cats using saliva.
Westman ME; Malik R; Hall E; Norris JM
Comp Immunol Microbiol Infect Dis; 2016 Jun; 46():66-72. PubMed ID: 27260813
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of polymerase chain reaction assays for diagnosis of feline immunodeficiency virus infection in cats.
Crawford PC; Slater MR; Levy JK
J Am Vet Med Assoc; 2005 May; 226(9):1503-7. PubMed ID: 15882000
[TBL] [Abstract][Full Text] [Related]
7. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
Kusuhara H; Hohdatsu T; Okumura M; Sato K; Suzuki Y; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
Vet Microbiol; 2005 Jul; 108(3-4):155-65. PubMed ID: 15899558
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of CD4%:CD8 low% T-lymphocyte ratio to differentiate feline immunodeficiency virus (FIV)-infected from FIV-vaccinated cats.
Litster A; Lin JM; Nichols J; Weng HY
Vet Microbiol; 2014 Jun; 170(3-4):197-205. PubMed ID: 24559863
[TBL] [Abstract][Full Text] [Related]
9. FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection.
Lutz H; Hofmann-Lehmann R; Bauer-Pham K; Holznagel E; Tozzini F; Bendinelli M; Reubel G; Aubert A; Davis D; Cox D
Vet Immunol Immunopathol; 1995 May; 46(1-2):103-13. PubMed ID: 7618250
[TBL] [Abstract][Full Text] [Related]
10. Preliminary evaluation of a quantitative polymerase chain reaction assay for diagnosis of feline immunodeficiency virus infection.
Ammersbach M; Little S; Bienzle D
J Feline Med Surg; 2013 Aug; 15(8):725-9. PubMed ID: 23362341
[TBL] [Abstract][Full Text] [Related]
11. An enzyme linked immunosorbent assay (ELISA) for the detection of feline immunodeficiency virus (FIV) antigen in cell culture and FIV specific antibodies in feline serum.
Siebelink CH; Windrich RW; Chu I; Groen J; Weijer K; UytdeHaag FG; Osterhaus AD
Dev Biol Stand; 1990; 72():189-96. PubMed ID: 2178115
[TBL] [Abstract][Full Text] [Related]
12. Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine.
Lehmann R; Franchini M; Aubert A; Wolfensberger C; Cronier J; Lutz H
J Am Vet Med Assoc; 1991 Nov; 199(10):1446-52. PubMed ID: 1666101
[TBL] [Abstract][Full Text] [Related]
13. Duration of antibody response following vaccination against feline immunodeficiency virus.
Westman ME; Malik R; Hall E; Harris M; Hosie MJ; Norris JM
J Feline Med Surg; 2017 Oct; 19(10):1055-1064. PubMed ID: 27770018
[TBL] [Abstract][Full Text] [Related]
14. Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus.
Lehmann R; von Beust B; Niederer E; Condrau MA; Fierz W; Aubert A; Ackley CD; Cooper MD; Tompkins MB; Lutz H
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):199-214. PubMed ID: 1363009
[TBL] [Abstract][Full Text] [Related]
15. New challenges for the diagnosis of feline immunodeficiency virus infection.
Crawford PC; Levy JK
Vet Clin North Am Small Anim Pract; 2007 Mar; 37(2):335-50, vii. PubMed ID: 17336678
[TBL] [Abstract][Full Text] [Related]
16. Diagnosing feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV) infection: an update for clinicians.
Westman ME; Malik R; Norris JM
Aust Vet J; 2019 Mar; 97(3):47-55. PubMed ID: 30809813
[TBL] [Abstract][Full Text] [Related]
17. Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection.
Hofmann-Lehmann R; Holznagel E; Aubert A; Ossent P; Reinacher M; Lutz H
Vet Immunol Immunopathol; 1995 May; 46(1-2):127-37. PubMed ID: 7618252
[TBL] [Abstract][Full Text] [Related]
18. Feline immunodeficiency virus diagnosis after vaccination.
Andersen PR; Tyrrell P
Anim Health Res Rev; 2004 Dec; 5(2):327-30. PubMed ID: 15984349
[TBL] [Abstract][Full Text] [Related]
19. Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins.
Leutenegger CM; Hofmann-Lehmann R; Holznagel E; Cuisinier AM; Wolfensberger C; Duquesne V; Cronier J; Allenspach K; Aubert A; Ossent P; Lutz H
AIDS Res Hum Retroviruses; 1998 Feb; 14(3):275-83. PubMed ID: 9491919
[TBL] [Abstract][Full Text] [Related]
20. Experimental vaccine protection against feline immunodeficiency virus.
Yamamoto JK; Okuda T; Ackley CD; Louie H; Pembroke E; Zochlinski H; Munn RJ; Gardner MB
AIDS Res Hum Retroviruses; 1991 Nov; 7(11):911-22. PubMed ID: 1662057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]